MillerKnoll Schedules First Quarter Fiscal Year 2025 Conference Call and Webcast
ZEELAND, Mich., Aug. 22, 2024 /PRNewswire/ — MillerKnoll, Inc. (NASDAQ: MLKN) will announce its financial results for the first quarter of fiscal year 2025... Read more.
LendingClub Bank Launches LevelUp Savings
Members Who Regularly Save Are Rewarded With a 5.30% Annual Percentage Yield (APY) SAN FRANCISCO, Aug. 22, 2024 /PRNewswire/ — LendingClub Bank, America’s... Read more.
HydrogenXT’s Financing Agreement with Carbonix Helps Launch Groundbreaking Avenal Project
Industry-Leading Hydrogen Fuel Innovator Secures Major Financing for Revolutionary Hydrogen Production and Distribution Facility HOUSTON and AVENAL, Calif., Aug.... Read more.
Zillow Group hires Soumya Tulloss as senior vice president of agent sales
Tulloss oversees Zillow’s agent sales team, which provides real estate agents advertising and software solutions to power their businesses SEATTLE, Aug. 22,... Read more.
Sesame Software Offers Unmatched Data Retention for Salesforce Users Amid Policy Changes
Sesame Software’s Backup/Replication Solution Ensures Data Accessibility Beyond Salesforce’s New 180-Day Limit SANTA CLARA, Calif., Aug. 22, 2024 /PRNewswire/... Read more.
IAS to Participate at Upcoming Investor Conferences
NEW YORK, Aug. 22, 2024 /PRNewswire/ — Integral Ad Science Holding Corp. (Nasdaq: IAS), a leading global media measurement and optimization platform, announced... Read more.
Whirlpool Corporation to Present at Goldman Sachs’ 31st Annual Global Retailing Conference
BENTON HARBOR, Mich., Aug. 22, 2024 /PRNewswire/ — Whirlpool Corporation (NYSE: WHR) announced today that it will participate in the Goldman Sachs 31st Annual... Read more.
10x Genomics to Present at the Morgan Stanley 22nd Annual Global Healthcare Conference
PLEASANTON, Calif., Aug. 22, 2024 /PRNewswire/ — 10x Genomics, Inc. (Nasdaq: TXG), a leader in single cell and spatial biology, announced today that members... Read more.
Jazz Pharmaceuticals Provides Update on Cannabidiol Oral Solution Phase 3 Trial in Japan in Treatment-Resistant Epilepsies
DUBLIN, Aug. 22, 2024 /PRNewswire/ — Jazz Pharmaceuticals plc (Nasdaq: JAZZ) today announced top-line results from the Phase 3 open-label, single-arm trial... Read more.
Workday Announces Fiscal 2025 Second Quarter Financial Results
Fiscal Second Quarter Total Revenues of $2.085 Billion, Up 16.7% Year Over YearSubscription Revenues of $1.903 Billion, Up 17.2% Year Over Year PLEASANTON, Calif.,... Read more.